A Multicenter, Prospective, Observational Study With PriMatrix for the Treatment of Neuropathic Diabetic Foot Ulcers

To evaluate the effectiveness of PriMatrix in the treatment of DFUs in subjects without significantly compromised arterial circulation.

Inclusion Criteria:

• Type I or Type II diabetes with investigator-confirmed reasonable metabolic control
• Peripheral neuropathy
• A full thickness diabetic plantar foot ulcer of at least 1 cm2 but not exceeding 10 cm2 in area
• An ulcer which has been in existence for a minimum of 30 days, prior to the day of screening

Exclusion Criteria:

• Suspected or confirmed signs/symptoms of wound infection
• Wounds with exposed bone or tendon
• Hypersensitivity to bovine collagen